Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma

OBJECTIVE: Programmed death-ligand 1 (PD-L1) was expressed in various tumors and antibodies targeting its receptor programmed cell death-1 (PD-1) are emerging cancer therapeutics. This study was designed to evaluate the expression of PD-L1 and its correlation with clinicopathologic features and clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jun, Wen, Hao, Bi, Rui, Wu, Yong, Wu, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641527/
https://www.ncbi.nlm.nih.gov/pubmed/29027395
http://dx.doi.org/10.3802/jgo.2017.28.e77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641527/
https://www.ncbi.nlm.nih.gov/pubmed/29027395
http://dx.doi.org/10.3802/jgo.2017.28.e77

Ejemplares similares